Abstract
BACKGROUND—Colorectal cancer is one of the leading causes of death from cancer in Western countries. Removal of adenomas is based on the assumption that it could lead to a reduction in the incidence of colorectal cancer, as demonstrated by the National Polyp Study in the USA. A critical issue is whether the benefit observed in clinical trials can also be observed in standard clinical practice. To address the issue, a multicentre Italian collaborative study was organised. METHODS—The study cohort comprised 1693 subjects of both sexes, aged 40-69 years, enrolled between 1980 and 1987 following a total colon examination (TCE) (that is, total colonoscopy or colonoscopy and double contrast barium enema), with removal of at least one adenoma larger than 5 mm in diameter. Exclusion criteria were genetic syndromes, previous adenomas or colorectal cancer, previous colonic resection, inflammatory bowel disease, or sessile adenomas more than 3 cm in diameter. Follow up ended in December 1996 by TCE or telephone interview, and review of the medical records, clinical files, or death certificates. Incidence ratios for colorectal cancer were compared with expected age and sex specific incidences in the Italian general population. RESULTS—Follow up data were obtained for 97.3% of cases for a total of 14 211 person/years. Mean follow up was 10.5 years. Six colorectal cancer cases (four in males, two in females) at various stages were ascertained (one at 29 months, two at five years, one at seven years, one at eight years, and one at 10 years from the index examination). The number of cancers expected in the reference population was 17.7 for an incidence ratio of 0.34 (confidence interval 0.23-0.63; p<0.01). CONCLUSIONS—Colonoscopic polypectomy substantially reduced the incidence of colorectal cancer in the cohort compared with that expected in the general population. These results are of particular relevance considering that those with adenomas are at increased risk of colorectal cancer and that this retrospective study was performed on data obtained in standard clinical practice. This observation strengthens the concept of effective population screening in view of the fact that adenomatous polyps are the most frequent neoplastic outcome of screening and their removal is associated with a decrease in the incidence of colorectal cancer. Keywords: colorectal cancer; colonoscopy; clinical practice; screening
Full Text
The Full Text of this article is available as a PDF (124.0 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Atkin W. S., Morson B. C., Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med. 1992 Mar 5;326(10):658–662. doi: 10.1056/NEJM199203053261002. [DOI] [PubMed] [Google Scholar]
- Capocaccia R., De Angelis R., Frova L., Gatta G., Sant M., Micheli A., Berrino F., Conti E., Gafà L., Roncucci L. Estimation and projections of colorectal cancer trends in Italy. Int J Epidemiol. 1997 Oct;26(5):924–932. doi: 10.1093/ije/26.5.924. [DOI] [PubMed] [Google Scholar]
- Capocaccia R., De Angelis R., Frova L., Sant M., Buiatti E., Gatta G., Micheli A., Berrino F., Barchielli A., Conti E. Estimation and projections of stomach cancer trends in Italy. Cancer Causes Control. 1995 Jul;6(4):339–346. doi: 10.1007/BF00051409. [DOI] [PubMed] [Google Scholar]
- Capocaccia R., Verdecchia A., Micheli A., Sant M., Gatta G., Berrino F. Breast cancer incidence and prevalence estimated from survival and mortality. Cancer Causes Control. 1990 Jul;1(1):23–29. doi: 10.1007/BF00053180. [DOI] [PubMed] [Google Scholar]
- De Angelis G., De Angelis R., Frova L., Verdecchia A. MIAMOD: a computer package to estimate chronic disease morbidity using mortality and survival data. Comput Methods Programs Biomed. 1994 Aug;44(2):99–107. doi: 10.1016/0169-2607(94)90091-4. [DOI] [PubMed] [Google Scholar]
- De Angelis R., Capocaccia R., Verdecchia A. Estimating relative survival of Italian cancer patients from sparse cancer registries data. Tumori. 1997 Jan-Feb;83(1):33–38. doi: 10.1177/030089169708300108. [DOI] [PubMed] [Google Scholar]
- De Angelis R., Valente F., Frova L., Verdecchia A., Gatta G., Chessa E., Berrino F. Trends of colorectal cancer incidence and prevalence in Italian regions. Tumori. 1998 Jan-Feb;84(1):1–8. doi: 10.1177/030089169808400101. [DOI] [PubMed] [Google Scholar]
- Hardcastle J. D., Chamberlain J. O., Robinson M. H., Moss S. M., Amar S. S., Balfour T. W., James P. D., Mangham C. M. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996 Nov 30;348(9040):1472–1477. doi: 10.1016/S0140-6736(96)03386-7. [DOI] [PubMed] [Google Scholar]
- Imperiale T. F., Wagner D. R., Lin C. Y., Larkin G. N., Rogge J. D., Ransohoff D. F. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med. 2000 Jul 20;343(3):169–174. doi: 10.1056/NEJM200007203430302. [DOI] [PubMed] [Google Scholar]
- Kronborg O., Fenger C., Olsen J., Jørgensen O. D., Søndergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996 Nov 30;348(9040):1467–1471. doi: 10.1016/S0140-6736(96)03430-7. [DOI] [PubMed] [Google Scholar]
- Lieberman D. A., Weiss D. G., Bond J. H., Ahnen D. J., Garewal H., Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med. 2000 Jul 20;343(3):162–168. doi: 10.1056/NEJM200007203430301. [DOI] [PubMed] [Google Scholar]
- Mandel J. S., Bond J. H., Church T. R., Snover D. C., Bradley G. M., Schuman L. M., Ederer F. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993 May 13;328(19):1365–1371. doi: 10.1056/NEJM199305133281901. [DOI] [PubMed] [Google Scholar]
- Mandel J. S., Church T. R., Bond J. H., Ederer F., Geisser M. S., Mongin S. J., Snover D. C., Schuman L. M. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000 Nov 30;343(22):1603–1607. doi: 10.1056/NEJM200011303432203. [DOI] [PubMed] [Google Scholar]
- Newcomb P. A., Norfleet R. G., Storer B. E., Surawicz T. S., Marcus P. M. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst. 1992 Oct 21;84(20):1572–1575. doi: 10.1093/jnci/84.20.1572. [DOI] [PubMed] [Google Scholar]
- Selby J. V., Friedman G. D., Quesenberry C. P., Jr, Weiss N. S. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992 Mar 5;326(10):653–657. doi: 10.1056/NEJM199203053261001. [DOI] [PubMed] [Google Scholar]
- Soussi T., Legros Y., Lubin R., Ory K., Schlichtholz B. Multifactorial analysis of p53 alteration in human cancer: a review. Int J Cancer. 1994 Apr 1;57(1):1–9. doi: 10.1002/ijc.2910570102. [DOI] [PubMed] [Google Scholar]
- Verdecchia A., Capocaccia R., Egidi V., Golini A. A method for the estimation of chronic disease morbidity and trends from mortality data. Stat Med. 1989 Feb;8(2):201–216. doi: 10.1002/sim.4780080207. [DOI] [PubMed] [Google Scholar]
- Winawer S. J., Flehinger B. J., Schottenfeld D., Miller D. G. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst. 1993 Aug 18;85(16):1311–1318. doi: 10.1093/jnci/85.16.1311. [DOI] [PubMed] [Google Scholar]
- Winawer S. J., Zauber A. G., Ho M. N., O'Brien M. J., Gottlieb L. S., Sternberg S. S., Waye J. D., Schapiro M., Bond J. H., Panish J. F. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993 Dec 30;329(27):1977–1981. doi: 10.1056/NEJM199312303292701. [DOI] [PubMed] [Google Scholar]